NTRA β€” NATERA INC

Ownership history in NWI MANAGEMENT LP  Β·  9 quarters on record

This page tracks every 13F SEC filing in which NWI MANAGEMENT LP reported a position in NATERA INC (NTRA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
14.39% (2025 Q1)
πŸ“Š Avg. % of fund
5.28%
πŸ“… First filed
2024 Q2
πŸ“… Last filed
2025 Q4
⏱ Quarters held
9

Position Intelligence

NWI MANAGEMENT LP Γ— NTRA AI Analytics

πŸ“ˆ NWI MANAGEMENT LP outperformed the S&P 500 by +29.3% annually on this NTRA position. Timing score: 43% (3/7 decisions correct). Average cost basis: $173.44. Maximum drawdown during holding period: –10.7%.

πŸ“ˆ Position Alpha vs SPY
+29.3%
annualised excess return

πŸ”₯ Exceptional β€” beat the S&P 500 by 29.3% per year on this position.
7 quarters analyzed

⏱️ Timing Score
43%

⚠️ Poor timing β€” buys often preceded drops, trims preceded rallies.
3 of 7 add/trim decisions correct

πŸ’° Entry Quality
$173.44
+32.1% vs current ($229.09)

Best entry: $126.95 (2024 Q3)  Β·  Worst: $229.09 (2025 Q4)

πŸ›‘οΈ Drawdown Resilience
–10.7%
max drawdown while held

πŸ’Ž No drawdown exceeding 20% during the holding period β€” exceptionally stable.

πŸ’ͺ Fund Conviction
67%
buy-side decisions

6 adds Β· 3 trims. Bought during 1 of 2 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
↓ Shrinking
last 4–5 quarters trend

πŸ“‰ Portfolio weight has been declining in recent quarters. Possible distribution phase.
Currently 0.71% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    NTRA price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 9 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 67,700 -694,903 -91.1% 0.71% $15.5M $229.09
2025 Q4 ADDED 762,603 +494,903 +184.9% 8.04% $174.7M $229.09
2025 Q3 REDUCED 267,700 -562,603 -67.8% 2.38% $43.1M $160.97
2025 Q3 REDUCED 830,303 -19,117 -2.3% 7.38% $133.7M $160.97
2025 Q2 ADDED 849,420 +39,420 +4.9% 7.55% $143.5M $168.94
2025 Q1 ADDED 810,000 +90,000 +12.5% 14.39% $114.5M $141.41
2024 Q4 ADDED 720,000 +180,000 +33.3% 5.02% $114.0M $158.30
2024 Q3 ADDED 540,000 +468,000 +650.0% 1.78% $68.6M $126.95
2024 Q2 INITIATED 72,000 β€” β€” 0.28% $7.8M β€”

🏒 Other funds also holding NTRA

As of 2025 Q4 β€” sorted by position size

Blue Water Life Science Advisors, LP 3Y 20.34% Sofinnova Investments, Inc. 3Y 7Y 15.31% Duquesne Family Office LLC 3Y 7Y 12.8% Lagoda Investment Management, L.P. 3Y 7Y 10.53% Foresite Capital Management V, LLC 3Y 9.39% Eagle Health Investments LP 3Y 9.23% PERKINS CAPITAL MANAGEMENT INC 3Y 7Y 8.1% Systrade AG 3Y 6.99% FARALLON CAPITAL MANAGEMENT LLC 3Y 7Y 4.23% Eversept Partners, LP 3Y 7Y 3.86%
← Back to NWI MANAGEMENT LP Holdings